CMRA - Chief Scientific Officer at Comera Life Sciences Acquires Company Stock Options Worth 300000 Shares | Benzinga
Patrick Robert Mahoney, Chief Scientific Officer at Comera Life Sciences (NASDAQ:CMRA), reported a large acquisition of company stock options on September 28, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Mahoney, Chief Scientific Officer at Comera Life Sciences, a company in the Health Care sector, was just awarded stock options worth 300,000 shares of CMRA. The options give Mahoney the right to buy the company's stock at $0.38 per share.
Comera Life Sciences shares are trading up 2.57% at $0.34 at the time of this writing on Friday morning. Since the current price is $0.34, this makes Mahoney's 300,000 shares worth ...